Semaglutide 1.7 mg: what it costs

1.7 mg is a price checkpoint as much as a clinical one. Here is what the board charges at this rung.

1.7 mg is step 4 of 5 on the semaglutide ladder, reached around weeks 13-16. The last step before the maintenance dose used in the major weight-management trial.

Because this is an early rung, the main cost question is not what 1.7 mg costs today but what happens when you reach the higher doses. Programmes that hold one price across the whole ladder are the ones that make that predictable.

What the board does at this dose

Roughly half our listings hold one price from the starting dose to the maximum. The rest re-price as you climb, which means the figure that got you in the door is not the figure you pay by the time the medication is working. That is the gap this page exists to show.

What 1.7 mg is for

1.7 mg is the last step before the maintenance dose, and it is a sensible place to pause if the previous increases have been hard. There is no obligation to move on after four weeks. Some people find this is where the balance between effect and side effects is best, and stay.

A reasonable place to pause for an extra month if the previous step was hard.

Where 1.7 mg sits on the ladder

Do you need to go higher than 1.7 mg?

Not necessarily. The ladder exists so that you can stop where the medication is working for you, and plenty of people settle below the maximum. Reaching the top dose is not a measure of success, and the trial figures are averages rather than targets.

How long can I stay at 1.7 mg? As long as it is working and your prescriber agrees. The four-week schedule is a default for titration, not a rule about maintenance.

The board caveat: compounded is not FDA-approved, approved pills start at $149, and Medicare hits $50 on 1 July 2026. Any listing that ignores those three facts is selling, not reporting.